Transmural heterogeneity of norepinephrine uptake in failing human hearts.

[1]  J. Saffitz,et al.  Heterogeneous Transmural Distribution of Beta‐Adrenergic Receptor Subtpes in Failing Human Hearts , 1993, Circulation.

[2]  P. Merlet,et al.  Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. , 1993, Circulation.

[3]  A. Quyyumi,et al.  Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine , 1992, Circulation.

[4]  P. Merlet,et al.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  L. Mestroni,et al.  Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. , 1992, The Journal of clinical investigation.

[6]  I. Meredith,et al.  Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. , 1991, The New England journal of medicine.

[7]  S. Sakamoto,et al.  Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation. , 1989, The Journal of clinical investigation.

[8]  J. Saffitz,et al.  Distribution of beta-adrenergic receptors in failing human myocardium. Implications for mechanisms of down-regulation. , 1989, Circulation.

[9]  J. Gordon,et al.  Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. , 1989, Circulation.

[10]  D. Goldstein,et al.  In vivo measurement of neuronal uptake of norepinephrine in the human heart. , 1988, Circulation.

[11]  J. Saffitz,et al.  Quantitative autoradiographic delineation of the distribution of beta-adrenergic receptors in canine and feline left ventricular myocardium. , 1987, Circulation research.

[12]  S. Jamieson,et al.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.

[13]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[14]  C. Rose,et al.  Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. , 1985, The Journal of clinical investigation.

[15]  D. Zipes,et al.  Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction. , 1985, Circulation.

[16]  K. Swedberg,et al.  Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. , 1984, The American journal of cardiology.

[17]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[18]  E. Sonnenblick,et al.  Combined renovascular hypertension and diabetes in rats: a new preparation of congestive cardiomyopathy. , 1984, Circulation.

[19]  C. Rose,et al.  Reduced aortocoronary sinus extraction of epinephrine in patients with left ventricular failure secondary to long-term pressure or volume overload. , 1983, Circulation.

[20]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[21]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[22]  T. K. Harden,et al.  Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process. , 1980, The Journal of biological chemistry.

[23]  K. Swedberg,et al.  Effects of work and acute beta‐receptor blockade on myocardial noradrenaline release in congestive cardiomyopathy , 1979, Clinical cardiology.

[24]  W. Nayler,et al.  Uptake of catecholamines by human cardiac muscle in vitro. , 1979, British heart journal.

[25]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[26]  A. L. Wit,et al.  Triggered and automatic activity in the canine coronary sinus. , 1977, Circulation research.

[27]  S. Banerjee,et al.  Inhibition of [3H]norepinephrine uptake in peripheral organs of some mammalian species by ouabain. , 1977, European journal of pharmacology.

[28]  M. Caron,et al.  Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Bassett,et al.  Depressed Transmembrane Potentials during Experimentally Induced Ventricular Failure in Cats , 1973, Circulation research.

[30]  E. Sonnenblick,et al.  Norepinephrine Stores and Contractile Force of Papillary Muscle from the Failing Human Heart , 1966, Circulation.

[31]  E. Braunwald,et al.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.

[32]  E. Braunwald,et al.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.

[33]  C. Coen,et al.  Sensitive method for determination of picogram amounts of epinephrine and other catecholamines in microdissected samples of rat brain using liquid chromatography with electrochemical detection. , 1988, Journal of chromatography.